Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

AGIO holding history

Agios Pharmaceuticals, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AGIO overviewAll 13F holders of AGIOFull Q2 2026 holdings

Shares (Q2 2026)
542
Value
$20.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of AGIO by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026542$20.1K<0.1%00.0%UnchangedHolders
Q1 2026542$18.3K<0.1%+33+6.5%AddedHolders
Q4 2025509$13.9K<0.1%−60−10.5%ReducedHolders
Q3 2025569$22.8K<0.1%00.0%UnchangedHolders
Q2 2025569$18.9K<0.1%+10+1.8%AddedHolders
Q1 2025559$16.4K<0.1%+76+15.7%AddedHolders
Q4 2024483$15.9K<0.1%+262+118.6%AddedHolders
Q3 2024221$9.82K<0.1%+68+44.4%AddedHolders
Q2 2024153$6.60K<0.1%−76−33.2%ReducedHolders
Q1 2024229$6.70K<0.1%−879−79.3%ReducedHolders
Q4 20231,108$24.7K<0.1%−248−18.3%ReducedHolders
Q3 20231,356$33.6K<0.1%−2,274−62.6%ReducedHolders
Q2 20233,630$102.8K<0.1%−141−3.7%ReducedHolders
Q1 20233,771$86.6K<0.1%+2+0.1%AddedHolders
Q4 20223,769$105.8K<0.1%−384−9.2%ReducedHolders
Q3 20224,153$118.0K<0.1%+160+4.0%AddedHolders
Q2 20223,993$88.0K<0.1%+3,680+1,175.7%AddedHolders
Q1 2022313$9.00K<0.1%−347−52.6%ReducedHolders
Q4 2021660$22.0K<0.1%−1,067−61.8%ReducedHolders
Q3 20211,727$80.0K<0.1%−112−6.1%ReducedHolders
Q2 20211,839$102.0K<0.1%+14+0.8%AddedHolders
Q1 20211,825$93.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.